Why the study?
Given the association of inflammation with suicide and ACS, the individual and interactive effects of serum TNF-alpha levels and two TNF-alpha polymorphisms on suicidal ideation after ACS were evaluated.
Are serum TNF-alpha levels and polymorphisms associated with suicidal ideation in patients with acute coronary syndrome?
Are serum TNF-alpha levels and polymorphisms associated with suicidal ideation in patients with acute coronary syndrome?
Serum TNF-alpha levels and specific polymorphisms may serve as time-specific biomarkers for suicidal ideation risk in patients recovering from acute coronary syndrome.
Answers are grounded in this paper and cite their sources.
May flag time-specific SI risk in ACS but should not yet change practice; leaves open confirmatory biomarker studies.
Background: Considering the association of inflammation with suicide and acute coronary syndrome (ACS), we investigated the individual and interactive effects of serum tumor necrosis factor-alpha (sTNFα) levels and two polymorphisms (−850 C / T and −308 G / A ) on suicidal ideation (SI) after ACS. Methods: The SI status using items on the Montgomery–Åsberg Depression Rating Scale (MADRS), related covariates including sociodemographic and clinical characteristics, sTNFα levels, and tumor necrosis factor-alpha (TNF-α) polymorphisms were evaluated in 969 patients within 2 weeks after ACS. Of the patients, 711 were evaluated 1 year later for SI. Multivariate logistic regression models were used to calculate individual and interactive associations after adjusting for the covariates. Results: Higher (vs. lower) sTNFα levels and the − 850 C / T or T/T (vs. C/C) polymorphism were significantly associated with SI 2 weeks after ACS, while only higher sTNFα levels were significantly associated with SI after 1 year. Significant interactive effects were detected between sTNFα (higher) levels and the − 850 C/T (C/C or C/T) polymorphism on SI 2 weeks after ACS and between the two (−850 CC or CT and − 308 G/A or AA ) polymorphisms on SI 1 year after ACS. Conclusions: The sTNFα level and two polymorphisms (−850C/ T and −308 G/A ), separately or in combination, could be time-specific biomarkers for SI in ACS. Focused interventions for ACS patients at risk of SI might reduce the suicidal burden in patients with ACS.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: